Filing Details

Accession Number:
0000950170-24-073250
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-13 19:58:48
Reporting Period:
2024-06-11
Accepted Time:
2024-06-13 19:58:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1538210 Neximmune Inc. NEXI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1843849 Kristi Jones C/O Neximmune, Inc.
9119 Gaither Road
Gaithersburg MD 20877
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Preferred Stock, Par Value $0.0001 Per Share Acquisiton 2024-06-11 1 $0.01 1 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On June 11, 2024, the Reporting Person purchased one (1) share of Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), of NexImmune, Inc. (the "Issuer") from the Issuer for cash consideration of $0.01. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series A Preferred Stock filed by the Issuer with the Secretary of State of the State of Delaware on June 11, 2024 (the "Series A COD"), including the right to have a number of votes equal to the number of outstanding shares of common stock,
  2. (Continued from footnote 1) par value $0.0001 per share ("Common Stock") on the record date for determining stockholders entitled to vote on such voting proposals defined in the Series A COD if the aggregate number of shares of Common Stock, present in person or by proxy and entitled to vote thereon that voted "for" a voting proposal is greater than the aggregate number of shares of Common Stock present in person or by proxy and entitled to vote thereon that voted "against" or "abstain" on such voting proposal.